Mariner Wealth Advisors »

Fate Therapeutics shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $29k 23k 1.26
2025-06-30 $13k 12k 1.12

More positions owned by Mariner Wealth Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Broadcom (AVGO)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Mariner Wealth Advisors

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Vestal Point Capital
Morgan Stanley
State Street Corporation
Dimensional Fund Advisors
Tang Capital Management
Goldman Sachs Group
Renaissance Technologies
AQR Capital Management

View all funds holding Fate Therapeutics